Chronic lymphocytic leukemia (CLL) is a type of cancer of the blood, marrow, and lymph nodes. It is the most common leukemia among adults.
You may have never experienced a prominent symptom before being diagnosed with this disease. Some patients find out only after routine blood work is performed. Unlike other more aggressive cancers, chronic lymphocytic leukemia is sometimes not treated right away because the disease may develop at a very slow and stable pace. Your treatment team can help you understand the various types of leukemia and you’ll be included in decisions about your care.
Why choose the Cancer Therapy & Research Center (CTRC) for chronic lymphocytic leukemia?
At the CTRC, hematologists who specialize in blood cancers lead the multidisciplinary team that comes together to diagnose, treat and listen to you. We have clinics and hospital-based units designed specifically to provide care for patients with leukemia. Our team includes pathologists who specialize in blood, marrow and lymph node cancers, also called hemato-pathologists. Clinical trial-based treatments are available. The CTRC’s hematology team partners with the National Cancer Institute and other organizations for clinical trial-based treatment options for all patients.
Clinical trials at the CTRC
All phases of clinical trials are available at the CTRC. If you and your care team decide to pursue treatment through a clinical trial, we’ll help you understand the steps involved in participating.
Make an appointment
To request an appointment with our team or to make a referral to one of our physicians, please call the CTRC main number: (210) 450-1000 or 800-340-2872 or email CTRCReferral@uthscsa.edu.